Annual Total Long Term Liabilities
$5.33 M
-$28.66 M-84.31%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual total long term liabilities is $5.33 million, with the most recent change of -$28.66 million (-84.31%) on December 31, 2023.
- During the last 3 years, PLX annual total long term liabilities has fallen by -$3.16 million (-37.21%).
- PLX annual total long term liabilities is now -95.30% below its all-time high of $113.58 million, reached on December 31, 2013.
Performance
PLX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$4.91 M
-$81.00 K-1.62%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly total long term liabilities is $4.91 million, with the most recent change of -$81.00 thousand (-1.62%) on September 30, 2024.
- Over the past year, PLX quarterly long term liabilities has dropped by -$1.06 million (-17.73%).
- PLX quarterly long term liabilities is now -95.91% below its all-time high of $120.03 million, reached on March 31, 2017.
Performance
PLX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PLX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.3% | -17.7% |
| 3 y3 years | -37.2% | -17.7% |
| 5 y5 years | -94.0% | -17.7% |
PLX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.5% | at low | -89.5% | at low |
| 5 y | 5-year | -92.9% | at low | -93.5% | at low |
| alltime | all time | -95.3% | >+9999.0% | -95.9% | -100.0% |
Protalix BioTherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.91 M(-1.6%) |
| Jun 2024 | - | $4.99 M(-4.3%) |
| Mar 2024 | - | $5.21 M(-2.3%) |
| Dec 2023 | $5.33 M(-84.3%) | $5.33 M(-10.5%) |
| Sep 2023 | - | $5.96 M(-77.3%) |
| Jun 2023 | - | $26.31 M(-22.7%) |
| Mar 2023 | - | $34.04 M(+0.1%) |
| Dec 2022 | $34.00 M(-26.9%) | $34.00 M(+0.2%) |
| Sep 2022 | - | $33.92 M(-14.3%) |
| Jun 2022 | - | $39.57 M(-2.4%) |
| Mar 2022 | - | $40.55 M(-12.9%) |
| Dec 2021 | $46.52 M(+447.5%) | $46.52 M(+14.9%) |
| Sep 2021 | - | $40.51 M(+399.1%) |
| Jun 2021 | - | $8.12 M(+9.3%) |
| Mar 2021 | - | $7.43 M(-12.6%) |
| Dec 2020 | $8.50 M(-88.8%) | $8.50 M(-86.2%) |
| Sep 2020 | - | $61.73 M(-3.6%) |
| Jun 2020 | - | $64.06 M(-3.1%) |
| Mar 2020 | - | $66.13 M(-12.5%) |
| Dec 2019 | $75.54 M(-14.8%) | $75.54 M(-17.2%) |
| Sep 2019 | - | $91.26 M(-5.7%) |
| Jun 2019 | - | $96.73 M(+3.1%) |
| Mar 2019 | - | $93.86 M(+5.9%) |
| Dec 2018 | $88.66 M(+12.3%) | $88.66 M(-24.6%) |
| Sep 2018 | - | $117.64 M(+36.4%) |
| Jun 2018 | - | $86.22 M(+4.2%) |
| Mar 2018 | - | $82.74 M(+4.8%) |
| Dec 2017 | $78.92 M(+203.6%) | $78.92 M(+30.4%) |
| Sep 2017 | - | $60.54 M(-0.0%) |
| Jun 2017 | - | $60.55 M(-49.6%) |
| Mar 2017 | - | $120.03 M(+361.8%) |
| Dec 2016 | $25.99 M(-65.4%) | $25.99 M(-65.5%) |
| Sep 2016 | - | $75.24 M(-0.2%) |
| Jun 2016 | - | $75.38 M(-0.0%) |
| Mar 2016 | - | $75.38 M(+0.3%) |
| Dec 2015 | $75.14 M(+8.0%) | $75.14 M(-28.5%) |
| Sep 2015 | - | $105.15 M(-0.4%) |
| Jun 2015 | - | $105.57 M(-1.0%) |
| Mar 2015 | - | $106.65 M(+53.2%) |
| Dec 2014 | $69.60 M | $69.60 M(-35.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $108.11 M(-1.1%) |
| Jun 2014 | - | $109.26 M(-0.9%) |
| Mar 2014 | - | $110.21 M(-3.0%) |
| Dec 2013 | $113.58 M(+101.6%) | $113.58 M(+0.8%) |
| Sep 2013 | - | $112.64 M(+136.3%) |
| Jun 2013 | - | $47.66 M(-8.0%) |
| Mar 2013 | - | $51.82 M(-8.0%) |
| Dec 2012 | $56.33 M(-4.8%) | $56.33 M(+8.0%) |
| Sep 2012 | - | $52.17 M(-5.3%) |
| Jun 2012 | - | $55.11 M(-3.7%) |
| Mar 2012 | - | $57.20 M(-3.4%) |
| Dec 2011 | $59.19 M(+3.6%) | $59.19 M(-1.1%) |
| Sep 2011 | - | $59.87 M(-0.7%) |
| Jun 2011 | - | $60.31 M(+7.5%) |
| Mar 2011 | - | $56.09 M(-1.9%) |
| Dec 2010 | $57.15 M(-6.7%) | $57.15 M(-1.8%) |
| Sep 2010 | - | $58.20 M(-3.1%) |
| Jun 2010 | - | $60.04 M(-0.6%) |
| Mar 2010 | - | $60.41 M(-1.4%) |
| Dec 2009 | $61.26 M(+6437.7%) | $61.26 M(+5259.4%) |
| Sep 2009 | - | $1.14 M(+8.2%) |
| Jun 2009 | - | $1.06 M(+15.2%) |
| Mar 2009 | - | $917.00 K(-2.1%) |
| Dec 2008 | $937.00 K(+35.8%) | $937.00 K(-5.7%) |
| Sep 2008 | - | $994.00 K(+2.8%) |
| Jun 2008 | - | $967.00 K(+10.9%) |
| Mar 2008 | - | $872.00 K(+26.4%) |
| Dec 2007 | $690.00 K(+58.3%) | $690.00 K(+9.7%) |
| Sep 2007 | - | $629.00 K(+11.7%) |
| Jun 2007 | - | $563.00 K(+10.4%) |
| Mar 2007 | - | $510.00 K(+17.0%) |
| Dec 2006 | $436.00 K(+53.0%) | $436.00 K(+53.0%) |
| Dec 2005 | $285.00 K(>+9900.0%) | $285.00 K(>+9900.0%) |
| Dec 2004 | $1000.00(-97.9%) | $1000.00(>+9900.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Sep 1999 | - | $36.60 K(-10.3%) |
| Jun 1999 | - | $40.80 K(0.0%) |
| Mar 1999 | - | $40.80 K |
| Dec 1998 | $47.90 K(-99.4%) | - |
| Dec 1997 | $7.38 M(+1.6%) | - |
| Dec 1996 | $7.26 M | - |
FAQ
- What is Protalix BioTherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual total long term liabilities year-on-year change?
- What is Protalix BioTherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly long term liabilities year-on-year change?
What is Protalix BioTherapeutics annual total long term liabilities?
The current annual total long term liabilities of PLX is $5.33 M
What is the all time high annual total long term liabilities for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual total long term liabilities is $113.58 M
What is Protalix BioTherapeutics annual total long term liabilities year-on-year change?
Over the past year, PLX annual total long term liabilities has changed by -$28.66 M (-84.31%)
What is Protalix BioTherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PLX is $4.91 M
What is the all time high quarterly long term liabilities for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly total long term liabilities is $120.03 M
What is Protalix BioTherapeutics quarterly long term liabilities year-on-year change?
Over the past year, PLX quarterly total long term liabilities has changed by -$1.06 M (-17.73%)